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osting by EAbstract Dextranases catalyze the hydrolysis of the a-l,6-glucosidic bond of the polysaccharide
dextran. Dextranases have been isolated from bacteria, yeast and fungi. Puriﬁed dextranase enzyme
from Penicillium sp. was PEGylated (polyethylene glycol modiﬁcation) with mPEG (5000 Da) and
showed an increase in the dextranase protein molecular weight as estimated by Superose 12 (23 ml)
column and this increment in the molecular weight is directly proportional to mPEG (5000 Da) con-
centration until a complete dextranase enzyme PEGylation (disappearance of dextranase peak). The
residual activity of partially PEGylated dextranase (mPEG 5000 of 5.8 mg/ml) was 33.8% and for
the completely PEGylated dextranase (mPEG 5000 of 29 mg/ml) it was 25.75%. Dextranase PEGy-
lated with mPEG (30,000 Da) showed a little PEGylation at mPEG concentration of 5.8 mg/ml but
at a concentration of 29 mg/ml several PEGylated peaks were produced with a difference in dex-
tranase activity toward dextran T500, retardation in the activity with the increasing in the molecular
weight was clearly appeared with Sephadex G75 but for Sephadex G200 a little retardation than
Sephadex G75 has been appeared.
ª 2012 Academy of Scientific Research & Technology. Production and hosting by Elsevier B.V.
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lsevier1. Introduction
Dextranase (EC 3.2.1.11 a-D-glucan-6-glucanohydrolase) is
an enzyme capable of hydrolyzing the a-1,6-glucosidic
bond of dextran producing either glucose or isomaltose
(endo-dextranase), or isomalto-oligosaccharides (exo-dextranase)
depending on the enzyme source [1]. Dextranase plays an
important role in sugar industry by reducing dextran forma-
tion, dental plaque treatment and production of low molecular
weight clinical dextran [2–4].
PEGylation is a procedure of increasing interest for enhanc-
ing the therapeutic and biotechnological potential of peptides
and proteins. When polyethylene glycol (PEG) is properly
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the main biological functions, such as enzymatic activity or
receptor recognition, may be maintained. PEG conjugation
masks the protein’s surface and enlarges the molecular size
of the polypeptide, thus reducing its renal ultraﬁltration, pre-
venting the approach of antibodies or antigen processing cells
and reducing the degradation by proteolytic enzymes [5]. PEG
has also approved to be used as a vehicle or base in foods, cos-
metics and pharmaceuticals, including injectable, rectal topical
and nasal formulations. PEG shows little toxicity, and is elim-
inated from the body intact by either the kidneys (for
PEGs < 30 kDa) or in the feces (for PEGs > 20 kDa) [6].
Mumtaz and Bachhawat [7] modiﬁed dextranase enzyme with
PEG and used liposomes as carrier for delivering both free and
PEG-modiﬁed dextranase to the liver of mice at similar rate
and they found that the PEG-dextranase showed a greater
intracellular stability as compared with the native enzyme.
The PEG-dextranase could not only degrade the accumu-
lated FITC-dextran but could also prevent further accumula-
tion over a period. The low molecular mass endoglucanase
from Fusarium oxysporium was chemically modiﬁed by two
distinct types of amino acid speciﬁc modiﬁers, cyanuric chlo-
ride activated polyethylene glycol (CC-PEG) and polyethylene
glycol succinimidyl succinate active ester (SS-PEG) speciﬁc for
lysine attachment and maleimide polyethylene glycol (Mal-
PEG) speciﬁc for cysteine attachment. Almost total activity
loss occurred in the case of enzyme reaction with CC-PEG.
In contrast there was no inactivation after enzyme reaction
with SS-PEG and Mal-PEG. The modiﬁed endoglucanase
showed remarkably enhanced stability against alkaline pH. It
was also found that the modiﬁed enzyme cleaved preferably
the internal glucosidic bonds of cellotetraose, cellopentaose
and CMC. Thus the modiﬁed enzyme retains the endocharac-
ter of the native enzyme [8]. L-asparaginase, an important en-
zyme used in leukemia treatment, was modiﬁed through
polyethylene glycol (PEG) conjugation in order to reduce the
hypersensitivity reactions caused by the enzyme. The PEGylat-
ed enzyme exhibited less immunogenicity with much longer
half-time of plasmatic life [9]. This research is undertaken with
the objective of studying the dextranase PEGylation with spe-
ciﬁc reference to its chromatographic and the hydrolytic
properties.Figure 1 Size exclusion chromatography on Superose 12. A
sample of 200 lL of a previously puriﬁed dextranase (0.45 mg/ml
protein) was loaded to Superose 12 FPLC column (23 ml).
Linear ﬂow rate 1 ml/min. UV absorbance at 280 nm.2. Materials and methods
2.1. Materials and equipments
Puriﬁed dextranase enzyme from Penicillium sp. was used as
the PEGylated substrate. mPEG-SPA (Mwt. of 5000 and
30,000 Da) was purchased from Nektar. Superose 12
HR10/30 column (Pharmacia Biotech.); Superose 6 HR10/30
column; Superose 12 prep. grade column (100 ml); Dextran 5
of average Mwt., 5150; Dextran 10 of average Mwt.,10450,
Dextran 20 of average Mwt., 21450; Dextran 70 of average
Mwt., 70300; Dextran 150 average Mwt.,147550; Dextran
T250 of average Mwt., 238200 and dextran T500 were Phar-
macia biotechnology products. Amicon Ultraﬁltration cell
using Amicon Millipore membrane of 10 pk was also used to
concentrate enzyme samples. All chromatographic processes
were carried on A¨KTA FPLC (Amershampharmacia
Biotech.).2.2. Dextranase assay and protein measurement
Dextranase enzyme activity was measured by incubating the
enzyme with buffered dextran solution (2% dextran T250 dis-
solved in 0.05 M acetate buffer pH5) for 10 min at 55 C
[10,11]. The activity was measured by detecting the produced
reducing sugar using DNSA (3,5- dinitrosalicylic acid) accord-
ing to Miller [12]. One enzyme unit is deﬁned as the amount of
enzyme which liberates 1 l mole of reducing sugar (glucose
equivalent) per min at standard conditions. Protein had been
measured according to Bradford [13].2.3. PEGylation technique
The PEGylation procedure was done by mixing 0.5 ml of dex-
tranase (2 mg/ml) in 20 mM Tris buffer (pH 8) with 0.5 ml of
mPEG in an Eppendorff tube at room temperature for 10, 20,
30, 60 and 180 min. Two hundred microliter of the reaction
mixture were added to 50 ll of 0.2 M Bis–Tris buffer (pH 5),
to lower the pH to stop the reaction, and then 200 ll of this
mixture was applied to Superose 12 HR10/30 column and
the column was equilibrated with 20 mM Bis–Tris buffer (pH
5) containing 0.1 M NaCl. This experiment was done for
mPEG 5000 and 30,000 Da with different concentrations
(from 5.8 up to 116 mg/ml).
The pH adjustment of dextranase enzyme to 8 was done
using 20 mM Tris buffer pH 8 by exchanging the buffer solu-
tion using concentration with Amicon Ultraﬁltration cell and
dilution using Tris buffer several times to a ﬁnal product of
2 mg/ml dextranase in Tris buffer (pH 8). mPEG was dissolved
in the same buffer.2.4. Molecular weight estimation
Molecular weight determination was carried out using SDS/
PAGE Phastgel gradient 8-25 electrophoresis using low molec-
ular weight protein kits to detect the change in the molecular
weight of dextranase after PEGylation.
Figure 4 Size exclusion chromatography on Superose 12. A
sample of 200 lL of a reaction mixture of dextranase (2 mg/ml)
with mPEG 5000 (58 mg/ml) for 10 min was loaded to Superose 12
FPLC column (23 ml). Linear ﬂow rate 1 ml/min. UV absor-
bance at 280 nm.The same results were found with incubation
periods of 20, 30, 60 and 810 min.
Figure 2 Size exclusion chromatography on Superose 12. A
sample of 200 lL of mPEG 5000 (11.6 mg/ml) was loaded to
Superose 12 FPLC column (23 ml). Linear ﬂow rate 1 ml/min.
UV absorbance at 280 nm.
Figure 3 Size exclusion chromatography on Superose 12. A
sample of 200 lL of a reaction mixture of dextranase (2 mg/ml)
with mPEG 5000 (11.6 mg/ml) for 10 min was loaded to Superose
12 FPLC column (23 ml). Linear ﬂow rate 1 ml/min. UV
absorbance at 280 nm. The same chromatogram has been seen
with 20, 30, 60 and 180 min.
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Pure dextranase enzyme in a concentration of 0.45 mg/ml
(200 ll) was loaded to a Superose 12 HR 10/30 with a total
volume of about 23 ml. The column was equilibrated with
20 mM Bis–Tris buffer (pH 5) containing 0.1 M NaCl. A single
peak was produced (Fig. 1). Two hundred microliter of a solu-
tion of 11.6 mg/ml of mPEG (5000 Da) was also loaded to the
same column under the same conditions and a single peak was
produced with an elution volume (21 ml) more than the pure
dextranase enzyme (Fig. 2). Moreover, dextranase enzyme in
a concentration of 2 mg/ml (in 20 mM Tris buffer, pH8) was
mixed with 11.6 mg/ml of mPEG (dissolved in Tris buffer,
pH8) for different incubation periods, 10, 20, 30, 60 andFigure 5 SDS/PAGE of samples from PEGylated of dextranase.
Lane 1&5, LMW caliberation kit proteins (Amersham Pharmacia
Biotech.); Lane 2, the residual dextranase after PEGylation with
mPEG 5000 (5.8 mg/ml); Lane 3, the PEGylated dextranase by
mPEG 5000 (5.8 mg/ml); lane 4, the PEGylated dextranase
by mPEG 5000 (29 mg/ml). Protein stained with silver nitrate.
Figure 6 Size exclusion chromatography on Superose 12. A
sample of 200 lL of a reaction mixture of dextranase (2 mg/ml)
with mPEG 30,000 (11.6 mg/ml) for 10 min was loaded to
Superose 12 FPLC column (23 ml). Linear ﬂow rate 1 ml/min.
UV absorbance at 280 nm. The same chromatogram has been
produced with different incubation periods (20, 30, 60 and
180 min.
Table 2 Effect of PEGylation (11.6 mg/ml mPEG 30,000 Da) on dextranase activity upon different substrates.
Substrate Activity (U/ml) Speciﬁc activity (U/mg prptein) % to each control
Enzyme + T500 (control) 4884.82 18787.77 100
PEGylated enzyme + T500 1074.16 6767.19 36
Enzyme + Sephadex G200 (control) 2123.32 13376.89 100
PEGylated enzyme + SephadexG200 815.99 5197.39 38.85
Enzyme + Sephadex G75 (control) 1079.55 6801.17 100
PEGylated enzyme + Sephadex G75 355.81 2266.31 33.32
Figure 7 Size exclusion chromatography on Superose 12. A
sample of 200 lL of a reaction mixture of dextranase (2 mg/ml)
with mPEG 30,000 (29 mg/ml) for 10, 20, 30, 60 and 180 min
separately was loaded to Superose 12 FPLC column (23 ml).
Linear ﬂow rate 1 ml/min. UV absorbance at 280 nm.
Table 3 Effect of different dextrans of different molecular
weights on the activity of PEGylated dextranase (29 mg/ml
mPEG 30,000) for 10 min using the same amount of protein in
relation to the UV absorbance at 280 nm.
Dextran (MWt.) Peak activity (U/ml)
2 3 4 5 6
5000 42.74 59.81 57.59 46.77 60.64
10,000 60.37 80.35 90.34 83.26 115.74
20,000 93.87 122.12 106.16 108.65 142.38
70,000 88.26 108.79 137.80 111.71 150.71
150,000 82.43 111.71 125.86 117.26 150.29
250,000 88.95 122.12 141.27 124.34 162.36
Table 1 Determination of dextranase activity and speciﬁc activity for different peggulated dextranase with different concentration of
mPEG (5000).
Sample Activity (U/ml) Speciﬁc activity (U/mg protein) Residual activity (%)
Original dextranase 4884.82 18787.77 100
PEGylated with 5.8 mg/ml mPEG 5000 1651.40 6351.53 33.81
PEGylated with 29 mg/ml mPEG 5000 1248.95 4803.96 25.57
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curred partially (three peaks with 12.5, 14.5 and 21 elution vol-
ume corresponding to mPEG-dextranase, free dextranase and
free mPEG, respectively) without any change with different
incubation periods (Fig. 3).
Results in Fig. 4 showed a complete PEGylation that oc-
curred when a solution of 2 mg/ml of dextranase was mixed
with equal volume of solution of 58 mg/ml of mPEG
5000 Da (both the enzyme and the mPEG were dissolved in
Tris buffer, pH 8). The complete PEGylation was not affected
by the time of incubation. The dextranase activity of unPEGy-
lated, partially PEGylated and complete PEGylated peaks has
been measured in terms of speciﬁc activity and residual activity
(%) in relation to the original dextranase enzyme that also
measured. It has been found that the unPEGylated dextranase
peak showed a residual activity of 100% and the partially
PEGylated dextranase peak (5.8 mg/ml mPEG 5000 Da)
showed a residual activity of 33.81 but the completely PEGy-
lated peak (29 mg/ml mPEG 5000 Da) showed a residual dex-
tranase activity of 25.6% (Table 1). The molecular weight of
these three peaks have been estimated by SDS/PAGE electro-
phoresis using Phast gel gradient 8-25 and compared to LMW
proteins kit and it has been found that the unPEGylated dex-
tranase peak had the same molecular weight of the original en-
zyme, but the partially PEGylated and the completely
PEGylated had higher molecular weights in the order of par-
tially and completely PEGylated dextranase (Fig. 5).
On the other hand, high molecular weight mPEG
(30,000 Da) had also been used to PEGylate dextranase en-
zyme. mPEG in concentration of 11.6 mg/ml was mixed with
dextranase enzyme of a concentration of 2 mg/ml for different
incubation periods (10, 20, 30, 60 and 180 min). It was found
that a very little portion of the enzyme has been PEGylated
and with prolonged incubation time, no further effect on the
degree of PEGylation had been observed (Fig. 6). Dextranase
activity was measured for the PEGylated part with dextran
T500, Sepadex G75 and Sephadex G200. It was found that
the PEGylated dextranase retained a residual activity of
36%, 12% and 27% for dextran T500, Sephadex G75 and
Sephadex G200, respectively (Table 2).With the use of mPEG (30,000 Da) in a concentration of
29 mg/ml to PEGylate dextranase enzyme having a concentra-
tion of (2 mg/ml), the enzyme showed a PEGylation with dif-
Figure 8 (a, b and c): Size exclusion chromatography on
Superose 12. A sample of 200 lL of a reaction mixture of
dextranase (2 mg/ml) with mPEG 30,000 (58 mg/ml) for 10 min
was loaded to Superose 12 FPLC column (23 ml). Linear ﬂow
rate 1 ml/min. UV absorbance at 280 nm. The dotted line showed
the dextranase activity when dextan T500 (a), Sephadex G200 (b)
and Sephadex G75 (c) were used as a substrate, respectively. igure 9 (a, b, c and d): Size exclusion chromatography on
uperose 12. A sample of 200 lL of a reaction mixture of
extranase (2 mg/ml) with mPEG 30,000 (58 mg/ml) for 20, 30, 60
180 min, respectively, Linear ﬂow rate 1 ml/min. UV absor-
ance at 280 nm. The dotted line showed the dextranase activity
hen Dextran T500 was used as a substrate.
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(from Superose 12 column) produced from dextranase with
mPEG 30,000 (29 mg/ml). The dextranase activity with theF
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2Figure 10 Size exclusion chromatography on Superose 12. A
sample of 200 lL of a reaction mixture of dextranase (2 mg/ml)
with mPEG 30,000 (116 mg/ml) for 30 min was loaded to Superose
12 FPLC column (23 ml). Linear ﬂow rate 1 ml/min. UV
absorbance at 280 nm. The dotted line showed the dextranase
activity when Dextran T500 was used as a substrate.
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(dextran 5, 10, 20, 70, 150 and 250 kDa) has been investigated
for the different produced peaks and it was found that the
activity decreased with the increase of the molecular weight
and peak 1 (fraction 1, 0.5 ml) showed no activity with all
the dextrans used (Table 3).
A comparison of the activity of dextranase between dextran
500, Sephdex G75 and Sephadex G200 was done and it was
found that with the exception of fraction no. 1 (ﬁrst 0.5 ml)
a dextranase activity was found with dextran 500 and in case
of Sephadex G200 the ﬁrst two fractions were found to have
no activity and there was an activity with the others but in case
of Sephadex G75 no activity has been found up to fraction no
8 (Fig. 8a, b and c). Fig. 9a, b, c and d represent the PEGyla-
tion of dextranase (2 mg/ml) with mPEG 30,000 Da for differ-
ent incubation periods (20, 30, 60 and 180 min), respectively.
Also, the dextranase activity was plotted for each PEGylation
curve. On the other hand, Fig. 10 showed mPEG 30,000 Da of
a concentration of 116 mg/ml incubated with dextranase for
30 min.
4. Discussion
Polyethylene glycol (PEG) is a highly investigated polymer for
the covalent modiﬁcation of biological macromolecules and
surfaces for many pharmaceutical and biotechnological appli-
cations [14]. Compared to native dextranase, an average in-
crease in its molecular weight has been observed using gel
ﬁltration columns (Sephadex) and SDS/PAGE studies. These
results are approximately equivalent to that investigated by
Christakopolous et al. [8] when they studied the PEGylation
of endoglucanase from Fusarium oxysporium.
The PEGylation progress for dextranase was also estimated
using SDS/PAGE technique and it was found that the PEGy-
lation increased with increasing the mPEG concentration and
the period of incubation. Diwan and Park [15] studied the
SDS/PAGE of lys-mPEG conjugate and the results gave a
mixture of different lysosome-mPEG conjugates and their re-sults with SE-HPLC showed the mono-, di-, and tri-PEGylated
derivatives of lyzosome. Weider et al. [16] studied the electro-
phoresis of partially puriﬁed preparation of O-phenylealanine
ammonia lyase using SDS/PAGE. They investigated that the
PEGylated enzyme results in great decrease in electrophoretic
mobility and formes a single band at the top of the gel. Fee [17]
found a shift in the peak areas with time, showing a reduction
in the native protein peak of a-lactalbumin and b-lactoglobulin
when both PEGylated and examined by gel-ﬁltration.
By increasing the degree of dextranase PEGylation the
activity showed a considerable decrease and the stability in-
creased. The cellulase complex from Trichoderma reesei was
polyethylene glycol (PEG)-modiﬁed with considerable reten-
tion of endo-beta-1,4-glucanase activity, as evaluated by the
carboxymethylcellulase (CMCase) assay. While resistance to-
wards heat denaturation was the same for either form, suscep-
tibility towards proteolysis was slightly greater for the PEG-
conjugate, in contrast to most reports using other enzymes
[18]. The loss of considerable activity following modiﬁcation
may be due to reaction of the coupling agent with essential
sulfhydryl groups [19]. Moreover, Freitas et al. [20] investi-
gated that uricase enzyme retained 87% and 75% of its activity
when PEGylated with mPEG-pNP and mPEG-CN,
respectively.
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